StockData

VitaNova Life Sciences Corp (VNOV) KPIs and segments

VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026Market cap $37.52MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive VitaNova Life Sciences's business

VitaNova Life Sciences's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

VitaNova Life Sciences's fiscal year ends April 30 — Q1 FY27 = CQ2 2026 (calendar quarter).

Periods
Add to chartMetric
Q1 FY27
Q4 FY26
Q3 FY26
Q2 FY26
Q1 FY26
Q4 FY25
Q3 FY25
Q2 FY25
Q1 FY25
Q4 FY24
Q3 FY24
Q2 FY24
Healthy Food Products($M)2
0.23
Sale Of Food Products($M)
0.23
Dietary Supplement Products($M)
0
Healthcare Segment($M)2
0.101.950.300.290.11
Sale Of Healthcare Products($M)
0.101.950.300.290.11
Consulting Service Income($M)
00000
Dietary Supplement Segment($M)3
0.090.720.710.420.101.950.300.29
Dietary Supplement Products($M)
0.090.720.710.420.101.950.300.29
Sale Of Food Products($M)
0
Consulting Service Income($M)
0000000
Consulting Service Segment($M)2
0.000.010.0000.010.000
Consulting Service Income($M)
0.000.010.0000.010.000
Sale Of Healthcare Products($M)
0000000
Other($M)2
0.00
Consulting Service Income($M)
0.00
Dietary Supplement Products($M)
0
Sale Of Healthcare Products($M)
0.710.420.101.950.300.290.11
Sale Of Food Products($M)
0.23
Dietary Supplement Products($M)
0.090.10
Consulting Service Income($M)
00.000.010.0000.010.000
Unites States Of America($M)
1.640.510.430.100.890.200.1200.050.030
Hong Kong SAR China($M)
0.150.20000.770.110.090.110.0800
China($M)
0000.300.010.080.4100
Healthcare Segment($M)
0.051.150.170.120.05
Dietary Supplement Segment($M)
-0.03-0.410.300.230.051.150.170.12
Other($M)
-0.08
Healthy Food Products($M)
-0.09
Consulting Service Segment($M)
-0.25-0.13-0.08-0.06-0.06-0.06-0.09
Healthcare Segment($M)2
0.061.160.180.150.07
Sale Of Healthcare Products($M)
0.061.160.180.150.07
Consulting Service Income($M)
00000
Dietary Supplement Segment($M)3
0.020.170.310.250.061.160.180.15
Dietary Supplement Products($M)
0.020.170.310.250.061.160.180.15
Sale Of Food Products($M)
0
Consulting Service Income($M)
0000000
Healthy Food Products($M)2
0.01
Sale Of Food Products($M)
0.01
Dietary Supplement Products($M)
0
Consulting Service Segment($M)2
0.000.010.0000.010.000
Consulting Service Income($M)
0.000.010.0000.010.000
Sale Of Healthcare Products($M)
0000000
Other($M)2
0.00
Consulting Service Income($M)
0.00
Dietary Supplement Products($M)
0
Sale Of Healthcare Products($M)
0.310.250.061.160.180.150.07
Dietary Supplement Products($M)
0.020.06
Sale Of Food Products($M)
0.01
Consulting Service Income($M)
00.000.010.0000.010.000
Earlier reporting (last reported 2024)2

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-09-14.

See a number that looks wrong?